Literature DB >> 9176113

Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse.

S Charan1, K Palmer, P Chester, A R Mire-Sluis, A Meager, N Edington.   

Abstract

Up to 21 days after exposure to live or ultraviolet-inactivated equid herpesvirus type-1 (EHV-1) autologous serum from ponies caused an immunosuppressive effect if incorporated into T-cell proliferation assays to EHV-1. The suppressive factor in the sera of ponies also inhibited T-cell response to phytohaemagglutinin. Increased levels of circulating activated transforming growth factor-beta 1 (TGF-beta 1) were detected, and the suppressive activity of the serum could be reversed by antibody to TGF-beta 1. In a challenge experiment the ponies which exhibited circulating TGF-beta 1 activity succumbed to infection while the ones with similar magnitudes of T-cell responses, but no TGF-beta 1 activity, were protected. A definition of this immunosuppressive mechanism and its mode of induction must be central to the design of vaccines and to an understanding of the pathogenesis of EHV-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176113      PMCID: PMC1456683          DOI: 10.1046/j.1365-2567.1997.00202.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Serological and virological investigations of an equid herpesvirus 1 (EHV-1) abortion storm on a stud farm in 1985.

Authors:  J A Mumford; P D Rossdale; D M Jessett; S J Gann; J Ousey; R F Cook
Journal:  J Reprod Fertil Suppl       Date:  1987

2.  Equine interferons following exposure to equid herpesvirus-1 or -4.

Authors:  N Edington; C G Bridges; L Griffiths
Journal:  J Interferon Res       Date:  1989-08

3.  Transforming growth factor-beta inhibits the generation of cytotoxic T cells in virus-infected mice.

Authors:  A Fontana; K Frei; S Bodmer; E Hofer; M H Schreier; M A Palladino; R M Zinkernagel
Journal:  J Immunol       Date:  1989-11-15       Impact factor: 5.422

4.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.

Authors:  J A Mumford; J Bates
Journal:  Vet Rec       Date:  1984-04-14       Impact factor: 2.695

6.  Variation in cellular tropism between isolates of equine herpesvirus-1 in foals.

Authors:  J R Patel; N Edington; J A Mumford
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

7.  Lymphocyte responses to virus and mitogen in ponies during experimental infection with equine herpesvirus 1.

Authors:  S K Dutta; A Myrup; M K Bumgardner
Journal:  Am J Vet Res       Date:  1980-12       Impact factor: 1.156

8.  Antibodies to peptide determinants in transforming growth factor beta and their applications.

Authors:  K C Flanders; A B Roberts; N Ling; B E Fleurdelys; M B Sporn
Journal:  Biochemistry       Date:  1988-01-26       Impact factor: 3.162

9.  Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils.

Authors:  G R Grotendorst; G Smale; D Pencev
Journal:  J Cell Physiol       Date:  1989-08       Impact factor: 6.384

10.  Innate immunity during Equid herpesvirus 1 (EHV-1) infection.

Authors:  C G Bridges; N Edington
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

View more
  5 in total

1.  Alpha/beta and gamma interferons are induced by infection with noncytopathic bovine viral diarrhea virus in vivo.

Authors:  B Charleston; L S Brackenbury; B V Carr; M D Fray; J C Hope; C J Howard; W I Morrison
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever.

Authors:  R Agarwal; E A Elbishbishi; U C Chaturvedi; R Nagar; A S Mustafa
Journal:  Int J Exp Pathol       Date:  1999-06       Impact factor: 1.925

3.  Equid herpesvirus 1 infection of endothelial cells requires activation of putative adhesion molecules: an in vitro model.

Authors:  D Smith; A Hamblin; N Edington
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

4.  Validation of quantitative polymerase chain reaction assays for measuring cytokine expression in equine macrophages.

Authors:  Charlotte A Allen; Susan L Payne; Melissa Harville; Noah Cohen; Karen E Russell
Journal:  J Immunol Methods       Date:  2007-09-04       Impact factor: 2.303

5.  Evaluation of immune responses following infection of ponies with an EHV-1 ORF1/2 deletion mutant.

Authors:  Gisela Soboll Hussey; Stephen B Hussey; Bettina Wagner; David W Horohov; Gerlinde R Van de Walle; Nikolaus Osterrieder; Lutz S Goehring; Sangeeta Rao; David P Lunn
Journal:  Vet Res       Date:  2011-02-07       Impact factor: 3.683

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.